Creutzfeldt Jakob disease masquerading as severe depression: a case report by Pithon, Camila et al.
Letter to the editor
Address for correspondence: Gustavo Leal. Hospital Universitário Professor Edgard Santos, Psiquiatria. Rua Augusto Viana, SN, Canela, 3º andar, Enf. 3B – 40110-040 – Salvador, BA, Brazil.  
E-mail: gustavocgl@hotmail.com
Creutzfeldt Jakob disease masquerading as severe depression: a case report
Camila Pithon1, Gustavo C. leal1, luCas C. Quarantini1,2, marlos roCha3
1 Psychiatry Service, University Hospital, Federal University of Bahia (UFBA), Salvador, BA, Brazil.
2 Postgraduate Program in Medicine and Health, Federal University of Bahia (UFBA), Salvador, BA, Brazil.
3 Neurology Service, University Hospital, Federal University of Bahia (UFBA), Salvador, BA, Brazil.
Received: 04/18/2018 – Accepted: 06/25/2018
DOI: 10.1590/0101-60830000000168
Pithon C et al. / Arch Clin Psychiatry. 2018;45(4):106
Dear Editor,
Cognitive disorders and depression are intensely correlated, not 
only by sharing risk factors, but also by frequently showing similar 
presentations. This might lead to challenging cases among the elderly 
population, since, in old age, depression commonly manifests with 
prominent neurovegetative and cognitive symptoms1. Here we report 
the case of a patient who had been treated, but after clinical evaluation 
demonstrated to be a case of sporadic Creutzfeldt-Jakob disease 
(sCJD), a rare and fatal neurodegenerative condition.
A 77 year-old female, without relevant psychiatric or medical 
history. Six months before admission, she presented with increasingly 
irritability and sadness. Within days, clinical condition declined, 
progressing to mutism, lack of interaction, anorexia, immobility 
and was treated with different combinations of antidepressants and 
antipsychotics, with the hypothesis of major depression. She was 
then referred to the Psychiatry inpatient unit of the local University 
Hospital for diagnostic investigation and clinical support. Mental 
status examination at admission was compatible with stupor, but three 
days later she begin to show spontaneous high amplitude myoclonus 
and intermittent inhibitory paratonia in inferior limbs, leading us to 
request Neurology consultation. Previous electroencephalography 
showed no relevant findings, but new analysis of a previous MRI 
demonstrated hyperintensity in cortex and caudate at DWI, suggestive 
of sCJD (Figure 1). Cerebrospinal fluid was sent to specific analyses 
and it was later confirmed presence of 14-3-3 protein. This, altogether 
with neurological deterioration and MRI images, reinforced the 
high probability of prion disease. Myoclonus were not evident at 
admission probably due to continuous use of benzodiazepines before 
hospitalization. Because it is an invariably fatal pathology, palliative 
care was instituted and family opted for home-care.
Prion encephalopathies are caused by an abnormal isoform of a 
cellular glycoprotein known as a prion, with an infective potential. 
The most frequent form of prion diseases is sCJD, it affects one in 
every million people and has no known source of infection2. Death 
usually occurs between 6 and 24 months of illness. About 20% present 
only with behavioral symptoms at the onset3, but up to 90% will show 
psychiatric manifestations at some point of illness evolution, mainly 
agitation, hallucinations, depression and anxiety4. 
Definite diagnosis of sCJD can only be made through direct 
analysis of brain tissue. A probable diagnosis is established in the 
presence of rapidly progressive dementia and two of the following: 
akinetic mutism, myoclonus, visual/cerebellar signs, pyramidal/
extrapyramidal signs; plus one of the tests: EEG with periodic 
sharp-wave complexes, positive 14-3-3, or MRI with high signal 
abnormalities in caudate/putamen on DWI or FLAIR; and with 
routine investigation not suggestive of alternative conditions5. 
Even when a diagnosis of CJD seems probable, the lack of definite 
noninvasive diagnosis and the irreversibility of the condition, 
frequently leads clinicians to attempt empirical treatment for other 
possible etiologies. 
This case demonstrates that sCJD is a possible underdiagnosed 
disease that can be clinically presented masquerade as major 
depressive disorder. We encourage close collaboration between 
Neurology and Psychiatry when faced with a patient presenting with 
a rapid and progressive cognitive deterioration. 
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disease. Brain. 2009;132(10):2659-68.Figure 1. MRI axial cuts showing hyperintensity in areas of the cortex 
(cortical ribboning) and in caudate nucleus at the DWI sequence. 
